European Pharmaceutical Review

MARCH 27, 2023

The research includes historic market data from 2017 to 2021, using 2022 as the base year. million in 2017 and continued to grow until 2021. In the report, analysts showed North America was the largest revenue contributor to the global rapid microbiology testing market in 2022, with the US being the leading country.

Marketing 112

Marketing Pharmaceutical research Pharmaceutical Leads 112

World of DTC Marketing

DECEMBER 2, 2021

” So, are we supposed to believe that better images in DTC ads lead to patients asking for an Rx? Ad recall is essential for CPGs, but for prescription drugs, the question that’s missing is “what action did it lead to? Higher numeracy was associated with better gist and verbatim recall.” ” Uh…no.

Food and Drug Administration 185

Food and Drug Administration Side effects FDA Prescription 185

Clarivate

APRIL 14, 2022

Our research shows that Ukraine has contributed more than 5,000 scientific publications towards the UN Sustainable Development Goals since 2017, including on peace and justice initiatives (SDG-16). According to our data, Ukraine contributed a total of 5,863 scientific publications towards SDGs since 2017 (see figure 2).

Government 133

Government Education Distribution Food 133

Clarivate

APRIL 21, 2022

As can be seen from Figure 1, between 2017-2021, Ukraine’s research output focused on macro topics such as physics (19%), clinical and life sciences (16%), chemistry (16%), social sciences (12%), engineering and material sciences (10%), and electrical engineering (10%) with a total of 52,618 papers published. Source: InCites.

Engineering 98

Engineering Education Electronics Medicine 98

World of DTC Marketing

FEBRUARY 1, 2022

According to STAT News “after a double-digit decline in 2021, the sector has fallen another 20% in the new year, erasing billions in value and leading even the most seasoned investors to question whether biotech has further to fall. It dropped more than 15% in 2016 and followed that up with a 44% rise in 2017.

Food and Drug Administration 234

Food and Drug Administration FDA Pharmaceutical Food 234

World of DTC Marketing

JUNE 27, 2021

Yet the media has led with “diabetes drug leads to major weight loss” Will doctors inform patients? SUMMARY: According to the NEJM “in participants with overweight or obesity, 2.4 But, will physicians tell patients that results depend on lifestyle intervention and a low-calorie diet?

Side effects 194

Side effects Patients Insurance Doctors 194

European Pharmaceutical Review

AUGUST 18, 2023

“This acceptance of our EU Marketing Authorisation Application is a key milestone in our global effort to help patients living with GA, a leading cause of blindness worldwide. This could therefore potentially slow the progression of GA. Astellas to accelerate ocular disease treatments with $5.9

Food and Drug Administration 87

Food and Drug Administration Medicine FDA Food 87

World of DTC Marketing

AUGUST 12, 2022

He leads the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital in Boston. Meanwhile, the top 25 pharmaceutical companies reported a “healthy average operating margin of 22 percent” at the end of 2017, according to an analysis by GlobalData.

Pharma 255

Pharma Retail Pharmaceutical manufacturing Pharmaceutical 255

European Pharmaceutical Review

JANUARY 11, 2024

The current medications (opioid and non-opioid) often force the patients to make an unfortunate choice between efficacy and debilitating side effects, leading to a cycling through multiple different therapies and suboptimal treatment response. 2017; 6(S1):1–3. Neuropathic pain: The scope of the problem. Pain and Therapy. Internet] NIH.

Medicine 86

Medicine Pharmacology Management Side effects 86

Spotio

MAY 10, 2023

Business-to-business (B2B) prospecting is the pillar of lead generation. According to Technology Advice , 70% of marketers at B2B companies reported that “improving lead quality” was the primary concern. Also, 54%said getting more leads was a top objective as well. Also, 54%said getting more leads was a top objective as well.

B2B Sales 98

B2B Sales Prospecting Sales CRM 98

World of DTC Marketing

MAY 13, 2021

Manhatten Research Taking The Pulse 2017. 2017 study. Physicians most often report using drug samples to avoid cost to the patient which may not lead to a written Rx. But what about online? Once again Medscape is number one. Medscape reaches over 3.6 million physicians worldwide, in multiple languages. Why are they number one?

Physicians 173

Physicians Marketing Drug Sample Pharma 173

European Pharmaceutical Review

MAY 10, 2023

The investment “strengthens Bavaria’s position as a leading biotechnology hub” and will help to generate “innovation and job growth” noted Bavarian Prime Minister Dr Markus Söder. Together with a previous site expansion in 2017, this new funding represents a total investment of nearly €100 million in the company’s German headquarters.

Manufacturing 90

Manufacturing Networking Medicine Biopharma 90

European Pharmaceutical Review

JULY 7, 2022

Brian Hughes replaces Hafrun Fridriksdottir who became Teva’s President of Global Generics R&D in 2017. . ” Since September 2021, Dr Hughes has been Senior Vice President of Clinical Development and Translational Medicine at Vertex Pharmaceuticals, based in Boston.

Medical 95

Medical Medicine Pharmaceutical Training 95

Legacy MEDSearch

MAY 3, 2023

Leadership includes Joy Celebre (recruiting since 1996, joined in 2008), Carolyn Jones (recruiting since 1995, joined in 2011), Arshad Alam (recruiting since 1995, joined 2017), John White (Talent Sourcing Manager, joined 2012), and Partner Chris Miclot, (joined 2012). “In

Recruitment 98

Recruitment Medical Management Media 98

Copyright Clearance Center

APRIL 11, 2024

Gervais became president of the International Association for the Advancement of Teaching and Research in Intellectual Property (ATRIP) in 2017 and was a Distinguished Fulbright Chair at Carleton University in 2022. His work was published in Science , several leading law reviews, and other peer-reviewed publications.

Government 52

Government Consulting Education Leads 52

World of DTC Marketing

FEBRUARY 19, 2021

Included in the programmatic ad errors is Pfizer, who developed a leading COVID vaccine. In early 2017, close to 40 percent of ad impressions served programmatically in the United States were fraudulent. When will pharma stop using programmatic online ads? Programmatic has been a thorn in online advertisers.

Pharma 180

Pharma Media Leads Marketing 180

Pharmaceutical Technology

NOVEMBER 17, 2022

This marks the first update to NICE’s endometriosis guidelines since 2017, representing a huge milestone for patients and practitioners alike. This delay in diagnosis ultimately leads to disease progression and associated complications, such as chronic pelvic pain and infertility, which greatly affects the patients’ quality of life.

Management 102

Management Pharmacology Side effects Patients 102

pharmaphorum

JULY 21, 2022

The appointment might raise some eyebrows given Roche’s need to drive pharma sales as it copes with the loss of patent protection on an earlier generation of antibody-based therapies – now being hit by biosimilar competition – but Schwan is confident Schinecker is the right man to lead the company forward.

Sales 105

Sales Pharma Competition Management 105

Pharmaceutical Technology

MARCH 10, 2023

GlobalData reviews the key events leading up to these current price trends in Lebanon. An average 236% price increase occurred in Lebanon between 2017-21 Signs of sharp price increases at the manufacturer level started back in 2021 due to the removal of state subsidies on many products.

Pharmaceutical 52

Pharmaceutical Medicine Insurance Marketing 52

PM360

OCTOBER 25, 2023

As the exclusive partner for GHMC in Mexico, Improve will play a pivotal role in connecting clients and organizations to GHMC’s international network of industry-leading professionals. February 2017. Mexico Overview.” Updated April 4, 2023. Accessed October 18, 2023. PricewaterhouseCooper. Accessed October 18, 2023.

Marketing 52

Marketing Networking Healthcare Healthcare 52

Clarivate

AUGUST 2, 2022

The CIRS study found that the FDA approved the highest number of NASs in 2021, continuing its streak of being the leading NAS approver since 2017. The CIRS study found that the number of products approved by all six agencies decreased by 23% from 2012-2016 (56 NASs) to 2017-2021 (43 NASs). FDA continues to approve the most NASs.

Medicine 98

Medicine Food and Drug Administration FDA Healthcare 98

pharmaphorum

OCTOBER 17, 2022

While a smaller patient group than menopausal women, carving out a niche in breast cancer could give Bayer an advantage over Astellas, which is currently in the lead with fezolinetant as it is due to hear from the FDA on a filing for the drug in menopausal VMS next February. There are around 2.3

Patients 99

Patients Medical FDA Leads 99

pharmaphorum

SEPTEMBER 14, 2022

SparingVision’s lead candidates are both targeting inherited retinal diseases (IRDs), a group which already has a gene therapy on the market in Novartis’ Luxturna (voretigene neparvovec), which was approved by the FDA in 2017 for biallelic RPE65 mutation-associated retinal dystrophy, a group which includes a small group of RP patients.

Safety 52

Safety Leads Patients FDA 52

Impetus Digital

MARCH 15, 2024

Emerging biopharma companies are responsible for over 70% of these products (up 20 percentage points from 2017) while Big Pharma has seen a declining share of the oncology pipeline, at only around 20% of products currently under development (down 15 percentage points from 2017).

Recruitment 83

Recruitment Healthcare Provider Patients Healthcare 83

PM360

OCTOBER 11, 2023

EVERSANA , a leading provider of global commercial services to the life sciences industry, today announced the acquisition of Healthware Group , a full-service agency and innovation consultancy headquartered in Salerno, Italy.

Networking 52

Networking Media Healthcare Healthcare 52

Pharmaceutical Technology

DECEMBER 8, 2022

Kite Pharma and Daiichi Sankyo have updated a partnership agreement signed in 2017 for the former’s CAR T-cell therapy, Yescarta (axicabtagene ciloleucel). Under the prior deal, Daiichi Sankyo acquired exclusive rights for the development, manufacturing and commercialisation of Yescarta in Japan.

Manufacturing 122

Manufacturing Marketing Engineering Patients 122

Pharmaceutical Technology

JULY 11, 2022

The lead product of the company, Giapreza (angiotensin II) obtained the Food and Drug Administration (FDA) approval in December 2017. La Jolla focuses on marketing innovative treatments that can enhance outcomes in patients with life-threatening diseases.

Pharmaceutical 59

Pharmaceutical Food and Drug Administration Distribution FDA 59

Pharmaceutical Technology

AUGUST 1, 2022

AMR is already the third leading cause of death worldwide, causing around 1.27 A 2017 article in Health Policy estimates that the cost of developing an antibiotic is around $1.5bn, while according to a 2020 article in Nature, the average revenue generated from an antibiotic’s sale is about $46m a year.

Government 93

Government Pharma Education Pharmaceutical 93

European Pharmaceutical Review

OCTOBER 21, 2022

A two-dose version of the vaccine was approved by the US Food and Drug Administration (FDA) in 2017. It causes severe hepatitis B infection that can lead to progressive liver disease. At the time, limited evidence was available surrounding its ability to protect people living with HIV.

Patients 83

Patients Food and Drug Administration Side effects Food 83

Pharmaceutical Technology

FEBRUARY 10, 2023

Undoubtedly, this has played a factor in the success of market-leading PD-1 inhibitors, Merck & Co.’s Notably, 2022 saw the greatest number of RSA deals arranged, surpassing the previous record in 2017, when the first gene therapy, Novartis’s Kymriah (tisagenlecleucel), was approved and priced at $475,000.

Marketing 105

Marketing Medicine Leads Safety 105

pharmaphorum

SEPTEMBER 1, 2022

He was due to start at GSK this morning to lead the commercial aspects of its business development, seeking out late-stage deal opportunities as the pharma group tries to build up its pipeline and step up sales growth in the wake of its separation from consumer health business Haleon. .

Pharma 80

Pharma Sales Leads Management 80

pharmaphorum

SEPTEMBER 11, 2022

Hard on the heels of a new $575 million partnership with GSK, US biotech SpringWorks Therapeutics has reported phase 3 data at ESMO that sets up regulatory filings for its lead drug nirogacestat in a rare and aggressive form of soft tissue cancer.

Side effects 52

Side effects Leads Safety Patients 52

LEVO Health

JANUARY 18, 2023

According to the Accenture report, 30% of people selected a new provider in 2021 (up from 26% in 2017), and 25% of those individuals switched providers because they were unhappy (up 18% from 2017). Patients are Holding Providers Accountable.

Healthcare 52

Healthcare Healthcare Patients Retail 52

pharmaphorum

JANUARY 3, 2023

A pharmacologist by training, Rawlins was the founding chairman of health technology assessment (HTA) agency NICE , leading the organisation from its inception in 1999 until 2013, and hired Sir Andrew Dillon to become the organisation’s founding chief executive.

Side effects 52

Side effects Medicine Safety Healthcare 52

Pharmaceutical Technology

MARCH 23, 2023

Note: Includes all completed deals from 2018 to 2022 as a % growth from the baseline year 2017. This would in turn lead to more early-stage biotech companies going public, driving innovation in drug development, and creating further opportunities for collaboration within the broader biopharmaceutical industry.

Marketing 59

Marketing Pharma Medicine Management 59

Pharmaceutical Technology

DECEMBER 12, 2022

The latest development comes after Kite Pharma and Daiichi Sankyo modified their collaboration agreement signed in 2017 for the former’s CAR T-cell therapy, Yescarta (axicabtagene ciloleucel). “Most importantly, this collaboration is focused on accelerating access for patients in need.”.

Manufacturing 105

Manufacturing Marketing Pharmaceutical Patients 105

pharmaphorum

NOVEMBER 20, 2022

billion to the biotech if the planned two lead projects met clinical and commercial objectives. The announcement comes just a few weeks after GSK also pulled out of two other T cell therapy based partnerships, one with Lyell Immunopharma first set up in 2019, and a second with Adaptimmune that dates back to 2017.

Leads 57

Leads 57